Back to Authors

Li, Youzhi

https://orcid.org/0000-0001-7152-5304

Mayo Clinic

Boston Biomedical (United States)

Citations 1

A phase Ib study of BBI608 in combination with FOLFIRI with and without bevacizumab in patients (pts) with advanced colorectal cancer (CRC).
Jonker, Derek J. , O’Neil, Bert H. , Hálfdánarson, Þorvarður R. , Li, Youzhi , Borodyansky, Laura, Li, Chiang, Halfdanarson, Thorvardur R , Hubbard, Joleen M. , Grothey, Axel

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3616-3616

10.1200/jco.2015.33.15_suppl.3616 Get It